Oncology Injection Drug Market Report

Europe Oncology Injection Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 09, 2020
  • PAGES：158
  • REPORT CODE：GMM465729
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Oncology Injection Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Oncology Injection Drug Market Segmentations:

    By Player:

    • Praecis Pharmaceuticals

    • AdvaCare

    • CordenPharma

    • Alza

    • S.G. Biopharm

    • Pharmascience

    • Genzyme

    • Taj Oncology

    • Ferring Pharmaceuticals

    • Eli Lilly

    • Millennium Pharmaceuticals

    • SG Biopharm

    • Debiopharm

    • Celgene

    • Allos Therapeutics

    By Type:

    • Organs

    • Central Nervous System

    • Circulatory/Musculoskeletal System

    By End-User:

    • Lymphoma

    • Myeloma

    • Prostate Cancer

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Injection Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Oncology Injection Drug Market Size and Growth Rate of Organs from 2014 to 2026

    • 1.3.2 Europe Oncology Injection Drug Market Size and Growth Rate of Central Nervous System from 2014 to 2026

    • 1.3.3 Europe Oncology Injection Drug Market Size and Growth Rate of Circulatory/Musculoskeletal System from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Oncology Injection Drug Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • 1.4.2 Europe Oncology Injection Drug Market Size and Growth Rate of Myeloma from 2014 to 2026

    • 1.4.3 Europe Oncology Injection Drug Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oncology Injection Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Injection Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Organs

      • 3.4.2 Market Size and Growth Rate of Central Nervous System

      • 3.4.3 Market Size and Growth Rate of Circulatory/Musculoskeletal System

    4 Segmentation of Oncology Injection Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Injection Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Injection Drug for Lymphoma

      • 4.4.2 Market Size and Growth Rate of Oncology Injection Drug for Myeloma

      • 4.4.3 Market Size and Growth Rate of Oncology Injection Drug for Prostate Cancer

    5 Market Analysis by Major Regions

    • 5.1 Europe Oncology Injection Drug Production Analysis by Top Regions

    • 5.2 Europe Oncology Injection Drug Consumption Analysis by Top Regions

    • 5.3 Europe Oncology Injection Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oncology Injection Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Oncology Injection Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oncology Injection Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oncology Injection Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oncology Injection Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oncology Injection Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oncology Injection Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Oncology Injection Drug Landscape Analysis

    • 7.1 Germany Oncology Injection Drug Landscape Analysis by Major Types

    • 7.2 Germany Oncology Injection Drug Landscape Analysis by Major End-Users

    8. UK Oncology Injection Drug Landscape Analysis

    • 8.1 UK Oncology Injection Drug Landscape Analysis by Major Types

    • 8.2 UK Oncology Injection Drug Landscape Analysis by Major End-Users

    9. France Oncology Injection Drug Landscape Analysis

    • 9.1 France Oncology Injection Drug Landscape Analysis by Major Types

    • 9.2 France Oncology Injection Drug Landscape Analysis by Major End-Users

    10. Italy Oncology Injection Drug Landscape Analysis

    • 10.1 Italy Oncology Injection Drug Landscape Analysis by Major Types

    • 10.2 Italy Oncology Injection Drug Landscape Analysis by Major End-Users

    11. Spain Oncology Injection Drug Landscape Analysis

    • 11.1 Spain Oncology Injection Drug Landscape Analysis by Major Types

    • 11.2 Spain Oncology Injection Drug Landscape Analysis by Major End-Users

    12. Poland Oncology Injection Drug Landscape Analysis

    • 12.1 Poland Oncology Injection Drug Landscape Analysis by Major Types

    • 12.2 Poland Oncology Injection Drug Landscape Analysis by Major End-Users

    13. Russia Oncology Injection Drug Landscape Analysis

    • 13.1 Russia Oncology Injection Drug Landscape Analysis by Major Types

    • 13.2 Russia Oncology Injection Drug Landscape Analysis by Major End-Users

    14. Switzerland Oncology Injection Drug Landscape Analysis

    • 14.1 Switzerland Oncology Injection Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Oncology Injection Drug Landscape Analysis by Major End-Users

    15. Turkey Oncology Injection Drug Landscape Analysis

    • 15.1 Turkey Oncology Injection Drug Landscape Analysis by Major Types

    • 15.2 Turkey Oncology Injection Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Oncology Injection Drug Market Volume and Growth Rate

      • 16.3.2 Finland Oncology Injection Drug Market Volume and Growth Rate

      • 16.3.3 Norway Oncology Injection Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Oncology Injection Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Oncology Injection Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Oncology Injection Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Oncology Injection Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Oncology Injection Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Oncology Injection Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Oncology Injection Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Oncology Injection Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Praecis Pharmaceuticals

      • 19.1.1 Praecis Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 AdvaCare

      • 19.2.1 AdvaCare Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 CordenPharma

      • 19.3.1 CordenPharma Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Alza

      • 19.4.1 Alza Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 S.G. Biopharm

      • 19.5.1 S.G. Biopharm Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pharmascience

      • 19.6.1 Pharmascience Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Genzyme

      • 19.7.1 Genzyme Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Taj Oncology

      • 19.8.1 Taj Oncology Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Ferring Pharmaceuticals

      • 19.9.1 Ferring Pharmaceuticals Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Eli Lilly

      • 19.10.1 Eli Lilly Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Millennium Pharmaceuticals

      • 19.11.1 Millennium Pharmaceuticals Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 SG Biopharm

      • 19.12.1 SG Biopharm Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Debiopharm

      • 19.13.1 Debiopharm Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Celgene

      • 19.14.1 Celgene Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Allos Therapeutics

      • 19.15.1 Allos Therapeutics Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 101 Figures and 139 Tables)

    • Figure Product Picture

    • Figure Europe Oncology Injection Drug Market Size and Growth Rate of Organs from 2014 to 2026

    • Figure Europe Oncology Injection Drug Market Size and Growth Rate of Central Nervous System from 2014 to 2026

    • Figure Europe Oncology Injection Drug Market Size and Growth Rate of Circulatory/Musculoskeletal System from 2014 to 2026

    • Figure Europe Oncology Injection Drug Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Europe Oncology Injection Drug Market Size and Growth Rate of Myeloma from 2014 to 2026

    • Figure Europe Oncology Injection Drug Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • Figure Germany Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Oncology Injection Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Injection Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Injection Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Injection Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Injection Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Organs

    • Figure Market Size and Growth Rate of Central Nervous System

    • Figure Market Size and Growth Rate of Circulatory/Musculoskeletal System

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Injection Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Injection Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Lymphoma

    • Figure Market Size and Growth Rate of Myeloma

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Table Europe Oncology Injection Drug Production by Major Regions

    • Table Europe Oncology Injection Drug Production Share by Major Regions

    • Figure Europe Oncology Injection Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Oncology Injection Drug Consumption by Major Regions

    • Table Europe Oncology Injection Drug Consumption Share by Major Regions

    • Table Germany Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table UK Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table France Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Italy Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Spain Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Poland Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Russia Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oncology Injection Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oncology Injection Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oncology Injection Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oncology Injection Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Germany Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table UK Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table UK Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table UK Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table France Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table France Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table France Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Italy Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Spain Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Poland Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Russia Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Turkey Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Oncology Injection Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Oncology Injection Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Oncology Injection Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Oncology Injection Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Praecis Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Praecis Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Praecis Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Praecis Pharmaceuticals

    • Table Product and Service Introduction of Praecis Pharmaceuticals

    • Table Company Profile and Development Status of AdvaCare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AdvaCare

    • Figure Sales and Growth Rate Analysis of AdvaCare

    • Figure Revenue and Market Share Analysis of AdvaCare

    • Table Product and Service Introduction of AdvaCare

    • Table Company Profile and Development Status of CordenPharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CordenPharma

    • Figure Sales and Growth Rate Analysis of CordenPharma

    • Figure Revenue and Market Share Analysis of CordenPharma

    • Table Product and Service Introduction of CordenPharma

    • Table Company Profile and Development Status of Alza

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alza

    • Figure Sales and Growth Rate Analysis of Alza

    • Figure Revenue and Market Share Analysis of Alza

    • Table Product and Service Introduction of Alza

    • Table Company Profile and Development Status of S.G. Biopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of S.G. Biopharm

    • Figure Sales and Growth Rate Analysis of S.G. Biopharm

    • Figure Revenue and Market Share Analysis of S.G. Biopharm

    • Table Product and Service Introduction of S.G. Biopharm

    • Table Company Profile and Development Status of Pharmascience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmascience

    • Figure Sales and Growth Rate Analysis of Pharmascience

    • Figure Revenue and Market Share Analysis of Pharmascience

    • Table Product and Service Introduction of Pharmascience

    • Table Company Profile and Development Status of Genzyme

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme

    • Figure Sales and Growth Rate Analysis of Genzyme

    • Figure Revenue and Market Share Analysis of Genzyme

    • Table Product and Service Introduction of Genzyme

    • Table Company Profile and Development Status of Taj Oncology

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taj Oncology

    • Figure Sales and Growth Rate Analysis of Taj Oncology

    • Figure Revenue and Market Share Analysis of Taj Oncology

    • Table Product and Service Introduction of Taj Oncology

    • Table Company Profile and Development Status of Ferring Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ferring Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ferring Pharmaceuticals

    • Table Product and Service Introduction of Ferring Pharmaceuticals

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Millennium Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Millennium Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Millennium Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Millennium Pharmaceuticals

    • Table Product and Service Introduction of Millennium Pharmaceuticals

    • Table Company Profile and Development Status of SG Biopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SG Biopharm

    • Figure Sales and Growth Rate Analysis of SG Biopharm

    • Figure Revenue and Market Share Analysis of SG Biopharm

    • Table Product and Service Introduction of SG Biopharm

    • Table Company Profile and Development Status of Debiopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm

    • Figure Sales and Growth Rate Analysis of Debiopharm

    • Figure Revenue and Market Share Analysis of Debiopharm

    • Table Product and Service Introduction of Debiopharm

    • Table Company Profile and Development Status of Celgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

    • Figure Sales and Growth Rate Analysis of Celgene

    • Figure Revenue and Market Share Analysis of Celgene

    • Table Product and Service Introduction of Celgene

    • Table Company Profile and Development Status of Allos Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allos Therapeutics

    • Figure Sales and Growth Rate Analysis of Allos Therapeutics

    • Figure Revenue and Market Share Analysis of Allos Therapeutics

    • Table Product and Service Introduction of Allos Therapeutics

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US